Bank of China Group Investment Investors
![](/files/companies/Bank%20of%20China%20Group%20Investment.png)
A consortium of Chinese investment firms have acquired stake in SciClone, a California Pharmaceutical firm, for $605 million.. Headquartered in Foster City California and listed on NASDAQ, SciClone is a revenue-generating pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
Founded Date:
Dec-84
Industry:
Finance
Technology:
DeepTech
Headquarters:
Hong Kong